Adam Bello, MD
Emergency Medicine · Jupiter, FLNPI 1871562413
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $967 of the $1,086 with a category attached, or 89.0%. 10 manufacturers reported payments, led by AstraZeneca at 36.4% of the total. Reporting peaked in 2023 at $309 and has fallen 79.2% since, to $64 in 2025. Among emergency medicine clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 57 payments — averaging $19.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$395
- Pfizer$150
- CSL Behring$129
- Johnson & Johnson$113
- Chiesi USA, Inc.$99
- UCB, Inc.$77
- plus $124 from 4 others
What the payments were for
- Food & beverage$96789%
- Education$11911%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 21 | $395 |
| Pfizer | 9 | $150 |
| CSL Behring | 7 | $129 |
| Johnson & Johnson(2 entities) | 2 | $113 |
| Chiesi USA, Inc. | 7 | $99 |
| UCB, Inc. | 4 | $77 |
| Lundbeck LLC | 3 | $52 |
| Mylan Specialty L.p. | 2 | $38 |
| Genentech USA, Inc. | 1 | $19 |
| Octapharma USA, Inc. | 1 | $16 |
How this compares
$1,086 in reported general payments places this provider in the 90th percentile of 3,289 emergency medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 35 | $187 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 17 | $155 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 25 | $127 |
| Tramadol Hcl | 62 | $106 |
| Doxycycline Hyclate | 11 | $93 |
| Ondansetron OdtOndansetron | 25 | $74 |
| Methylprednisolone | 15 | $64 |
| Ibuprofen | 24 | $53 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 18 | $51 |
Paid to pharmacies, not to this prescriber.
Other emergency medicine in Jupiter
- Laurent DreyfussSunrise$1.2M
- Jason WilsonTampa$538K
- Robert LutenJacksonville$190K
- Adam LeisyHialeah$148K
- Joseph TyndallGainesville$130K
- Kunal AgarwalMiami$101K
- Jason WilsonFort Myers$96K
- Latha GantiGainesville$86K
- Brandon AllenGainesville$80K
- Patricia PanakosMiami$76K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.